Showing results (1161-1170 of 1,350) with videos related to
Sort By:
Pageof 135
Drug Development Research|July 1, 2014
Biological evaluation and SAR analysis of O-methylated analogs of quercetin as inhibitors of cancer cell proliferationZhi-Hao Shi, Nian-Guang Li, Yu-Ping Tang, et al.Drug Development Research|August 9, 2020
Repurposing topical triclosan for cutaneous leishmaniasis: Preclinical efficacy in a murine Leishmania (L.) amazonensis modelJuliana Tonini Mesquita, Maiara Maria Romanelli, Cristiana de Melo Trinconi Trinconi Cm, et al.Drug Development Research|August 12, 2020
A novel salvianolic acid A analog with resveratrol structure and its antioxidant activities in vitro and in vivoJin-Mei Qiu, Chang-Feng Qin, Shen-Gen Wu, et al.Drug Development Research|August 12, 2020
Amino acid conjugates of 2-mercaptobenzimidazole provide better anti-inflammatory pharmacology and improved toxicity profileMuhammad T Khan, Humaira Nadeem, Arif-Ullah Khan, et al.Drug Development Research|August 13, 2020
A novel series of substituted 1,2,3-triazoles as cancer stem cell inhibitors: Synthesis and biological evaluationKomal N Padhariya, Maithili Athavale, Sangeeta Srivastava, et al.Drug Development Research|April 1, 2021
Changes in the proportions of an active pharmaceutical through cocrystalsAbhay Pratap Singh, Munendra Pal Singh, Jubaraj B BaruahDrug Development Research|July 14, 2020
TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2Xiaoyang Ji, Wenting Tan, Chunming Zhang, et al.Drug Development Research|August 22, 2020
The involvement of protein TNFSF18 in promoting p-STAT1 phosphorylation to induce coronary microcirculation disturbance in atherosclerotic mouse modelJing Gao, Sai Wang, Shilei LiuDrug Development Research|July 8, 2020
Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive reviewAbdullah Al Mamun Sohag, Md Abdul Hannan, Sadaqur Rahman, et al.Drug Development Research|March 29, 2023
Combination of chemotherapy and gaseous signaling molecular therapy: Novel β-elemene nitric oxide donor derivatives against leukemiaJunlong Zhu, Xiaoying Jiang, Xinyu Luo, et al.Pageof 135